Alissa J Cooper

9PUBLICATIONS
142CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Central nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 15, 2026
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.

Sarah Waliany, Alissa J Cooper, Stephen V Liu

|Nov 20, 2025
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.

Rohit Thummalapalli, Salomon Tendler, Joanne F Chou

|Oct 30, 2025
Multi-Institution Analysis of Tarlatamab for the Treatment of <i>EGFR</i>-Mutant Transformed Small Cell Lung Cancer.

Alissa J Cooper, Benjamin Herzberg, Mitchell Parma

|Sep 26, 2025
Bridging the Gap: The Evolving Landscape of CNS Management in Small Cell Lung Cancer: Prophylactic Cranial Irradiation in the Modern Era.

Tafadzwa L Chaunzwa, Salma K Jabbour, Luke R G Pike

|Sep 24, 2025
Clinical and Pathologic Landscapes of Delta-Like Ligand 3 and Seizure-Related Homolog Protein 6 Expression in Neuroendocrine Carcinomas.

Jessica S Ross, Rohit Thummalapalli, Kristine Lacuna

|Sep 09, 2025
Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survival.

Alissa J Cooper, Edoardo Garbo, Andrea Arfe

Pageof 2

Frequent Collaborators

4 joint publications

Charles M Rudin

3 joint publications

Natasha Rekhtman

2 joint publications

Helena Yu

2 joint publications

Rohit Thummalapalli